GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (OTCPK:MYCOF) » Definitions » 6-1 Month Momentum %

Mydecine Innovations Group (Mydecine Innovations Group) 6-1 Month Momentum %

: -91.11% (As of Today)
View and export this data going back to 2015. Start your Free Trial

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-04-18), Mydecine Innovations Group's 6-1 Month Momentum % is -91.11%.

The industry rank for Mydecine Innovations Group's 6-1 Month Momentum % or its related term are showing as below:

MYCOF's 6-1 Month Momentum % is ranked worse than
99.37% of 1113 companies
in the Drug Manufacturers industry
Industry Median: -2.64 vs MYCOF: -91.11

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Mydecine Innovations Group's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mydecine Innovations Group 6-1 Month Momentum % Distribution

For the Drug Manufacturers industry and Healthcare sector, Mydecine Innovations Group's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Mydecine Innovations Group's 6-1 Month Momentum % falls into.



Mydecine Innovations Group  (OTCPK:MYCOF) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mydecine Innovations Group  (OTCPK:MYCOF) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Mydecine Innovations Group 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Mydecine Innovations Group's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mydecine Innovations Group (Mydecine Innovations Group) Business Description

Traded in Other Exchanges
Address
789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.